Santhera Pharmaceuticals Holding(CH:SANN)
CHF 14.62-0.48 (-3.18%)
CH:SANN
Santhera Pharmaceuticals Holding financials statements
CHF 14.62
At close:-0.48 (-3.18%)
Want to see CH:SANN full AI Analyst Report?
Santhera Pharmaceuticals Holding (SANN) Ratios
6 Followers
Santhera Pharmaceuticals Holding Ratios
CH:SANN's free cash flow for Q2 2026 was CHF14.79M. For the 2026 fiscal year, CH:SANN's free cash flow was decreased by CHF-38.00K and operating cash flow was CHF14.82M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.29 | 1.64 | 0.78 | 0.06 | 0.75 |
| Quick Ratio | 0.89 | 1.26 | 0.74 | 0.06 | 0.74 |
| Cash Ratio | 0.36 | 0.89 | 0.69 | 0.03 | 0.65 |
| Solvency Ratio | -0.27 | -0.29 | 1.16 | -0.63 | -0.58 |
| Operating Cash Flow Ratio | -0.56 | -0.77 | 1.07 | -0.60 | -1.14 |
| Short-Term Operating Cash Flow Coverage | -2.44 | -5.11 | 2.26 | -1.35 | -2.43 |
| Net Current Asset Value | CHF -79.66M | CHF -48.98M | CHF -15.03M | CHF -104.35M | CHF -65.15M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.66 | 0.27 | 0.21 | 0.70 | 0.47 |
| Debt-to-Equity Ratio | -8.27 | 1.49 | 0.38 | -1.02 | 32.36 |
| Debt-to-Capital Ratio | 1.14 | 0.60 | 0.28 | 59.17 | 0.97 |
| Long-Term Debt-to-Capital Ratio | 1.19 | 0.53 | 0.02 | -0.93 | 0.95 |
| Financial Leverage Ratio | -12.53 | 5.51 | 1.83 | -1.46 | 68.61 |
| Debt Service Coverage Ratio | -1.25 | -0.60 | 1.87 | -1.12 | -1.11 |
| Interest Coverage Ratio | -3.27 | -1.66 | 3.23 | -2.57 | -3.46 |
| Debt to Market Cap | 0.53 | 0.25 | 0.22 | 0.51 | 0.91 |
| Interest Debt Per Share | 8.40 | 5.39 | 4.19 | 10.61 | 17.38 |
| Net Debt to EBITDA | -2.34 | -0.02 | -0.09 | -0.92 | -0.63 |
| Profitability Margins | |||||
| Gross Profit Margin | 18.74% | 58.69% | 96.87% | 51.93% | 336.18% |
| EBIT Margin | -48.99% | -55.05% | 73.62% | -674.79% | 2400.88% |
| EBITDA Margin | -41.62% | -40.62% | 76.56% | -625.97% | 2167.40% |
| Operating Profit Margin | -48.99% | -85.34% | 66.57% | -695.52% | 3566.65% |
| Pretax Profit Margin | -63.55% | -106.51% | 53.01% | -944.95% | 3430.53% |
| Net Profit Margin | -63.79% | -107.30% | 52.97% | -951.10% | 3481.25% |
| Continuous Operations Profit Margin | -63.79% | -107.30% | 52.97% | -951.10% | 3481.25% |
| Net Income Per EBT | 100.38% | 100.75% | 99.93% | 100.65% | 101.48% |
| EBT Per EBIT | 129.71% | 124.80% | 79.63% | 135.86% | 96.18% |
| Return on Assets (ROA) | -33.25% | -27.53% | 49.97% | -111.53% | -60.94% |
| Return on Equity (ROE) | 416.69% | -151.54% | 91.39% | 162.70% | -4181.17% |
| Return on Capital Employed (ROCE) | -44.02% | -31.39% | 105.40% | -363.16% | -97.52% |
| Return on Invested Capital (ROIC) | -37.53% | -29.32% | 79.23% | -140.24% | -76.55% |
| Return on Tangible Assets | -58.51% | -50.24% | 153.61% | -1572.48% | -209.37% |
| Earnings Yield | -30.02% | -26.70% | 52.79% | -84.53% | -122.18% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.96 | 2.82 | 235.03 | 6.85 | -0.82 |
| Payables Turnover | 4.62 | 1.68 | 0.91 | 0.92 | 1.56 |
| Inventory Turnover | 2.52 | 0.89 | 1.79 | 33.26 | 8.80 |
| Fixed Asset Turnover | 38.40 | 15.21 | 177.69 | 7.41 | -1.20 |
| Asset Turnover | 0.52 | 0.26 | 0.94 | 0.12 | -0.02 |
| Working Capital Turnover Ratio | 3.23 | 3.91 | -3.69 | -0.27 | 0.16 |
| Cash Conversion Cycle | 188.81 | 324.65 | -195.33 | -331.53 | -635.27 |
| Days of Sales Outstanding | 123.13 | 129.56 | 1.55 | 53.29 | -443.03 |
| Days of Inventory Outstanding | 144.72 | 411.83 | 204.33 | 10.97 | 41.47 |
| Days of Payables Outstanding | 79.05 | 216.73 | 401.22 | 395.79 | 233.71 |
| Operating Cycle | 267.85 | 541.39 | 205.89 | 64.26 | -401.56 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2.67 | -3.12 | 4.47 | -4.90 | -10.93 |
| Free Cash Flow Per Share | -2.68 | -3.14 | 2.22 | -5.55 | -10.94 |
| Dividend Paid and CapEx Coverage Ratio | -668.52 | -235.28 | 1.99 | -7.54 | -2490.60 |
| Capital Expenditure Coverage Ratio | -668.52 | -235.28 | 1.99 | -7.54 | -2490.60 |
| Operating Cash Flow Coverage Ratio | -0.36 | -0.86 | 2.05 | -0.67 | -0.87 |
| Operating Cash Flow to Sales Ratio | -0.45 | -0.91 | 0.46 | -3.99 | 23.42 |
| Free Cash Flow Yield | -21.23% | -22.70% | 22.67% | -40.20% | -82.24% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.33 | -3.75 | 1.89 | -1.18 | -0.82 |
| Price-to-Sales (P/S) Ratio | 2.12 | 4.02 | 1.00 | 11.25 | -28.49 |
| Price-to-Book (P/B) Ratio | -13.88 | 5.68 | 1.73 | -1.92 | 34.22 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.71 | -4.41 | 4.41 | -2.49 | -1.22 |
| Price-to-Operating Cash Flow Ratio | -4.72 | -4.42 | 2.20 | -2.82 | -1.22 |
| Price-to-Earnings Growth (PEG) Ratio | -1.37 | 0.02 | -0.01 | 0.04 | 0.01 |
| Enterprise Value Multiple | -7.45 | -9.91 | 1.22 | -2.72 | -1.94 |
| Enterprise Value | 239.31M | 157.45M | 96.43M | 127.16M | 67.21M |
| EV to EBITDA | -7.45 | -9.91 | 1.22 | -2.72 | -1.94 |
| EV to Sales | 3.10 | 4.03 | 0.93 | 17.02 | -42.14 |
| EV to Free Cash Flow | -6.87 | -4.41 | 4.10 | -3.76 | -1.80 |
| EV to Operating Cash Flow | -6.88 | -4.43 | 2.04 | -4.26 | -1.80 |
| Tangible Book Value Per Share | -5.82 | -3.63 | -1.33 | -16.89 | -18.52 |
| Shareholders’ Equity Per Share | -0.91 | 2.43 | 5.67 | -7.17 | 0.39 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.01 | 0.00 | -0.01 | -0.01 |
| Revenue Per Share | 5.93 | 3.44 | 9.78 | 1.23 | -0.47 |
| Net Income Per Share | -3.78 | -3.69 | 5.18 | -11.67 | -16.25 |
| Tax Burden | 1.00 | 1.01 | 1.00 | 1.01 | 1.01 |
| Interest Burden | 1.30 | 1.93 | 0.72 | 1.40 | 1.43 |
| Research & Development to Revenue | 0.29 | 0.68 | 0.18 | 4.09 | -18.63 |
| SG&A to Revenue | 0.40 | 0.76 | 0.20 | 1.95 | -7.98 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.06 | 0.73 | -1.73 |
| Income Quality | 0.71 | 0.85 | 0.86 | 0.42 | 0.68 |
Currency in CHF

